Cargando…

Susceptibility of Patients with Airway Disease to SARS-CoV-2 Infection

Detalles Bibliográficos
Autores principales:	Conway, Francesca M., Bloom, Chloe I., Shah, Pallav L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2022
Materias:	Pulmonary Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9799128/ https://www.ncbi.nlm.nih.gov/pubmed/35549839 http://dx.doi.org/10.1164/rccm.202111-2547PP

Ejemplares similares

Coughs and Sneezes: Their Role in Transmission of Respiratory Viral Infections, Including SARS-CoV-2
por: Dhand, Rajiv, et al.
Publicado: (2020)

Redox regulation of motile cilia in airway disease
por: Price, Michael E., et al.
Publicado: (2019)

Blood Eosinophil Counts in Clinical Trials for Chronic Obstructive Pulmonary Disease
por: Singh, Dave, et al.
Publicado: (2020)

Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary
por: Agustí, Alvar, et al.
Publicado: (2023)

Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection
por: Netea, Mihai G., et al.
Publicado: (2020)

SARS-CoV-2 and Male Infertility: Possible Multifaceted Pathology
por: Dutta, Sulagna, et al.
Publicado: (2020)

EVALUATION OF LUNG FUNCTION AFTER SARS-COV-2 PNEUMONIA
por: ORZES, NICLA, et al.
Publicado: (2021)

NO RELATIONSHIP BETWEEN PULMONARY FUNCTION AND EXERCISE CAPACITY IN PEOPLE WITH POSTACUTE SEQUELAE OF SARS-COV-2 INFECTION
por: BONVIE-HILL, NATALIE, et al.
Publicado: (2022)

The Structural and Social Determinants of the Racial/Ethnic Disparities in the U.S. COVID-19 Pandemic. What’s Our Role?
por: Thakur, Neeta, et al.
Publicado: (2020)

From GOLD 0 to Pre-COPD
por: Han, MeiLan K., et al.
Publicado: (2021)

Latent Tuberculosis: Two Centuries of Confusion
por: Behr, Marcel A., et al.
Publicado: (2021)

Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes
por: Reddel, Helen K., et al.
Publicado: (2021)

Aggressive Afterload Lowering to Improve the Right Ventricle: A New Target for Medical Therapy in Pulmonary Arterial Hypertension?
por: Vizza, Carmine Dario, et al.
Publicado: (2021)

Innate Immune Response in SARS-CoV-2 Infection
por: Schiuma, Giovanna, et al.
Publicado: (2022)

Superantigens and SARS-CoV-2
por: Hamdy, Adam, et al.
Publicado: (2022)

Role of the early secretory pathway in SARS-CoV-2 infection
por: Sicari, Daria, et al.
Publicado: (2020)

SARS-CoV-2 infection and the antiviral innate immune response
por: Yang, Hui, et al.
Publicado: (2020)

Realization of humoral immunity against SARS-CoV-2 infections
por: Lin, Yong, et al.
Publicado: (2021)

SARS-CoV-2 infections in children: Understanding diverse outcomes
por: Brodin, Petter
Publicado: (2022)

Improving Nasal Protection for Preventing SARS-CoV-2 Infection
por: Nocini, Riccardo, et al.
Publicado: (2022)

The Recombination Potential between SARS-CoV-2 and MERS-CoV from Cross-Species Spill-over Infections
por: Sajini, Abdulrahim A., et al.
Publicado: (2021)

Structural Analysis of the SARS-CoV-2 Omicron Variant Proteins
por: Yang, Qiangzhen, et al.
Publicado: (2021)

SARS-CoV-2 infection in children: Transmission dynamics and clinical characteristics
por: Cao, Qing, et al.
Publicado: (2020)

Mechanisms of infection by SARS-CoV-2, inflammation and potential links with the microbiome
por: Aguirre García, María Magdalena, et al.
Publicado: (2021)

Potential intestinal infection and faecal–oral transmission of SARS-CoV-2
por: Guo, Meng, et al.
Publicado: (2021)

Postacute sequelae of SARS-CoV-2 infection. Osteonecrosis must not be overlooked
por: Koutalos, Antonios A., et al.
Publicado: (2022)

Higher binding affinity of furin for SARS-CoV-2 spike (S) protein D614G mutant could be associated with higher SARS-CoV-2 infectivity
por: Mohammad, Anwar, et al.
Publicado: (2021)

Multilayer Scaling of a Biomimetic Microfluidic Oxygenator
por: Vedula, Else M., et al.
Publicado: (2022)

Protection from infection or disease? Re-evaluating the broad immunogenicity of inactivated SARS-CoV-2 vaccines
por: Tan, Anthony T., et al.
Publicado: (2022)

Cancer and Immune Checkpoint Inhibitor Treatment in the Era of SARS-CoV-2 Infection
por: Gambichler, Thilo, et al.
Publicado: (2020)

Update on Functional Inhibitors of Acid Sphingomyelinase (FIASMAs) in SARS-CoV-2 Infection
por: Loas, Gwenolé, et al.
Publicado: (2021)

SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact
por: Lipsitch, Marc, et al.
Publicado: (2021)

The Possible Role of Glucose-6-Phosphate Dehydrogenase in the SARS-CoV-2 Infection
por: Pérez-Torres, Israel, et al.
Publicado: (2022)

Vaccination against SARS-CoV-2 and disease enhancement – knowns and unknowns
por: Zellweger, Raphaël M., et al.
Publicado: (2020)

Equitable distribution of SARS-CoV-2 tests
por: Garcia-Bereguiain, Miguel Angel, et al.
Publicado: (2022)

SARS-CoV-2 and Arthropods: A Review
por: Higgs, Stephen, et al.
Publicado: (2022)

SARS-CoV-2 S Glycoprotein Stabilization Strategies
por: Pedenko, Borys, et al.
Publicado: (2023)

Stillbirth and fetal capillary infection by SARS-CoV-2
por: di Gioia, Cira, et al.
Publicado: (2022)

Dengue virus and SARS-CoV-2 Co-infection dynamics: An emerging threat among African countries
por: Oladipo, Habeebullah Jayeola, et al.
Publicado: (2022)

Early preemptive immunomodulators (corticosteroids) for severe pneumonia patients infected with SARS-CoV-2
por: Lee, Kyung-Yil, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i34k92266tf9umi3bkh5olmb0r